Articles with "vsv" as a keyword



Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment

Sign Up to like & get
recommendations!
Published in 2019 at "International Journal of Cancer"

DOI: 10.1002/ijc.32325

Abstract: The efficacy of cancer vaccines has been limited by the immunosuppressive tumor microenvironment, which can be alleviated by immune checkpoint inhibitor (ICI) therapy. Here, we tested if oncolytic viruses (OVs), similar to ICI, can also… read more here.

Keywords: cancer; vsv; tumor microenvironment; efficacy cancer ... See more keywords

Comparison of Voxel S-Value Methods for Personalized Voxel-based Dosimetry of 177 Lu-DOTATATE.

Sign Up to like & get
recommendations!
Published in 2022 at "Medical physics"

DOI: 10.1002/mp.15444

Abstract: PURPOSE Voxel-based dosimetry is potentially accurate than organ-based dosimetry because it considers the anatomical variations in each individual and the heterogeneous radioactivity distribution in each organ. Here, voxel-based dosimetry for 177 Lu-DOTATATE therapy was performed… read more here.

Keywords: vsv; based dosimetry; 177 dotatate; dosimetry ... See more keywords

Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus

Sign Up to like & get
recommendations!
Published in 2024 at "NPJ Vaccines"

DOI: 10.1038/s41541-024-00814-2

Abstract: Hantaan virus (HTNV) is a pathogenic orthohantavirus prevalent in East Asia that is known to cause hemorrhagic fever with severe renal syndrome (HFRS), which has a high fatality rate. However, a Food and Drug Administration… read more here.

Keywords: rvsv htnv; virus; vsv; vaccine ... See more keywords

Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge

Sign Up to like & get
recommendations!
Published in 2025 at "NPJ Vaccines"

DOI: 10.1038/s41541-025-01164-3

Abstract: Crimean-Congo hemorrhagic fever virus (CCHFV) causes a severe, sometimes fatal hemorrhagic fever (CCHF) in humans. Currently, there are no approved therapies against CCHF. In this study we used the recombinant vesicular stomatitis virus (VSV) platform… read more here.

Keywords: hemorrhagic fever; virus; vsv; vaccine ... See more keywords

Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine

Sign Up to like & get
recommendations!
Published in 2022 at "mBio"

DOI: 10.1128/mbio.03379-21

Abstract: The vesicular stomatitis virus (VSV) vaccine platform rose to fame in 2019, when a VSV-based Ebola virus (EBOV) vaccine was approved by the European Medicines Agency and the U.S. Food and Drug Administration for human… read more here.

Keywords: vsv; single dose; stomatitis virus; vesicular stomatitis ... See more keywords

Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression

Sign Up to like & get
recommendations!
Published in 2022 at "Journal for Immunotherapy of Cancer"

DOI: 10.1136/jitc-2021-003923

Abstract: Background Pancreatic cancer is one of the leading causes of cancer death, with a 5-year -year survival rate of less than 10%. This results from late detection, high rates of metastasis, and resistance to standard… read more here.

Keywords: cell; nkt cell; vsv; cell activation ... See more keywords

Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype

Sign Up to like & get
recommendations!
Published in 2025 at "Journal for Immunotherapy of Cancer"

DOI: 10.1136/jitc-2024-010675

Abstract: Background Vesicular stomatitis virus (VSV) pseudotyped with the glycoprotein (GP) of the lymphocytic choriomeningitis virus (VSV-GP) represents a potent oncolytic virus (OV). Oncolytic virotherapy is an emerging anticancer approach that uses viruses to eliminate cancer… read more here.

Keywords: virus vsv; cell; vsv; cell responses ... See more keywords

Molecular Pathology Methods to Characterize Biodistribution and Pharmacodynamics of the Oncolytic Virus VSV-GP in a Nonclinical Tumor Model

Sign Up to like & get
recommendations!
Published in 2025 at "Toxicologic Pathology"

DOI: 10.1177/01926233241303904

Abstract: Replication-competent oncolytic virus (OV) therapies are a promising new modality for cancer treatment. However, they pose unique challenges for preclinical assessment, due in part to their tumor specificity and ability to self-replicate in vivo. Understanding… read more here.

Keywords: pathology; virus; tumor; molecular pathology ... See more keywords

SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis

Sign Up to like & get
recommendations!
Published in 2025 at "Biomarker Research"

DOI: 10.1186/s40364-025-00726-w

Abstract: Oncolytic viruses (OVs) are increasingly recognized as promising tools for cancer therapy, as they selectively infect and destroy tumor cells while leaving healthy cells unharmed. Despite considerable progress, the limited therapeutic efficacy of OV-based virotherapy… read more here.

Keywords: virotherapy; panoptosis; pd1 blockade; cell ... See more keywords

Oncolytic Effect of a Recombinant Vesicular Stomatitis Virus Encoding a Tumor-suppressor MicroRNA in an Osteosarcoma Mouse Model

Sign Up to like & get
recommendations!
Published in 2023 at "AntiCancer Research"

DOI: 10.21873/anticanres.16264

Abstract: Background/Aim: Attempts have been made to enhance treatment with vesicular stomatitis virus (VSV) for osteosarcoma. We have previously shown that VSV incorporated with miRNA143 enhanced the antitumor effect at some doses; however, the range of… read more here.

Keywords: osteosarcoma; vsv; effect; tumor suppressor ... See more keywords

Single-step rapid chromatographic purification and characterization of clinical stage oncolytic VSV-GP

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Bioengineering and Biotechnology"

DOI: 10.3389/fbioe.2022.992069

Abstract: Purification of viruses, especially for therapeutic purposes, is a tedious and challenging task. The challenges arise due to the size and surface complexity of the virus particles. VSV-GP is a promising oncolytic virus, which has… read more here.

Keywords: purification; vsv; single step; virus ... See more keywords